Heinrich Heine University Düsseldorf-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2018

  1. Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))

    Redox Biology

  2. Novel indanone derivatives as MAO B/H3R dual-targeting ligands for treatment of Parkinson's disease

    European Journal of Medicinal Chemistry, Vol. 148, pp. 487-497

2017

  1. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

    Redox Biology, Vol. 13, pp. 94-162

  2. Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases

    Angewandte Chemie - International Edition, Vol. 56, Núm. 41, pp. 12765-12769

2015

  1. Predicting targets of compounds against neurological diseases using cheminformatic methodology

    Journal of Computer-Aided Molecular Design, Vol. 29, Núm. 2, pp. 183-198